Overall survival analyses of Kaplan Meier (KM)-plotter (left) and Gene Expression Profiling Interactive Analysis (GEPIA) (right) suggested that individuals with higher levels of CP expression had significantly shorter survival time compared with lung cancer patients with lower CP levels statistically (Figure 1D). The gene discussed is CP; the disease is lung carcinoma.